HomeCompareFLXI vs ABBV

FLXI vs ABBV: Dividend Comparison 2026

FLXI yields 0.43% · ABBV yields 3.67%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ABBV wins by $20.2K in total portfolio value
10 years
FLXI
FLXI
● Live price
0.43%
Share price
$48.27
Annual div
$0.21
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$19.7K
Annual income
$0.04
Full FLXI calculator →
ABBV
AbbVie Inc.
● Live price
3.67%
Share price
$168.90
Annual div
$6.20
5Y div CAGR
8.9%
Payout ratio
58%
After 10 yrs · $10,000 · DRIP
Portfolio value
$39.9K
Annual income
$1,154.43
Full ABBV calculator →

Portfolio growth — FLXI vs ABBV

📍 ABBV pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodFLXIABBV
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, FLXI + ABBV cover 4 of 12 monthsgood coverage

Jan
ABBV
Feb
Mar
Apr
ABBV
May
Jun
Jul
ABBV
Aug
Sep
Oct
ABBV
Nov
Dec
FLXI pays
ABBV pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

FLXI
Annual income on $10K today (after 15% tax)
$36.44/yr
After 10yr DRIP, annual income (after tax)
$0.03/yr
ABBV
Annual income on $10K today (after 15% tax)
$312.02/yr
After 10yr DRIP, annual income (after tax)
$981.27/yr
At 15% tax rate, ABBV beats the other by $981.23/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of FLXI + ABBV for your $10,000?

FLXI: 50%ABBV: 50%
100% ABBV50/50100% FLXI
Portfolio after 10yr
$29.8K
Annual income
$577.24/yr
Blended yield
1.94%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ABBV right now

FLXI
No analyst data
Altman Z
31.0
Piotroski
7/9
ABBV
Analyst Ratings
27
Buy
12
Hold
1
Sell
Consensus: Buy
Price Target
$256.15
+51.7% upside vs current
Range: $223.00 — $299.00
Altman Z
2.0
Piotroski
8/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

FLXI buys
0
ABBV buys
0
No recent congressional trades found for FLXI or ABBV in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricFLXIABBV
Forward yield0.43%3.67%
Annual dividend / share$0.21$6.20
Payout ratio50%58%
1-year div growth0%4.7%
5-year div CAGR-50%8.9%
Portfolio after 10y$19.7K$39.9K
Annual income after 10y$0.04$1,154.43
Total dividends collected$43.00$7.2K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: FLXI vs ABBV ($10,000, DRIP)

YearFLXI PortfolioFLXI Income/yrABBV PortfolioABBV Income/yrGap
1← crossover$10,721$21.43$11,520$399.75$799.00ABBV
2$11,483$10.74$13,261$450.98$1.8KABBV
3$12,292$5.37$15,255$508.41$3.0KABBV
4$13,155$2.69$17,536$572.74$4.4KABBV
5$14,077$1.34$20,145$644.78$6.1KABBV
6$15,063$0.67$23,126$725.38$8.1KABBV
7$16,118$0.34$26,532$815.52$10.4KABBV
8$17,246$0.17$30,420$916.26$13.2KABBV
9$18,454$0.08$34,855$1,028.80$16.4KABBV
10$19,746$0.04$39,914$1,154.43$20.2KABBV

FLXI vs ABBV: Complete Analysis 2026

FLXIStock

FlexiInternational Software Inc. develops, markets, and supports back office accounting software solutions for companies in banking and credit union, insurance, financial services, and other service industries worldwide. The company offers offers FlexiFinancials suite that consists of FlexiLedger, a core repository of financial transactions; FlexiPayables, an accounts payable module; FlexiPurchasing to track and streamline the purchasing processes; FlexiAssets, a fixed assets module; FlexiProjects that manages, tracks, and analyzes project costs, budgets, encumbrances, and status; FlexiFDW, an event-driven data repository; and FlexiReceivables for companies to manage and track their receivables. It also provides FlexiTools applications to customize FlexiFinancials, such as FlexiDesigner to customize the FlexiFinancials Suite GUI using an interactive visual design editor; and FlexiDB that allows the customization of the Flexi database structures. In addition, the company offers FlexiInfo Suite that consist of FlexiWorkflow, an application that is integrated with various FlexiFinancial modules; FlexiImaging that provides integration with various third party imaging solutions, including Microsoft SharePoint; and RenovoFYI, a Web based financial report writer. Further, it provides FlexiIntegration suite that consists of FlexiAPIs that provide real-time, synchronous access to functional components within the FlexiFinancials Suite of applications; FlexiNetExchange to provide a seamless integration with Jack Henry's Silverlake core banking solution, Synergy Workflow, and Synergy Imaging; and FlexiImport/Export Wizard that allow users to import and export data. Furthermore, the company offers consulting, training and education, and support services. It has strategic partnerships with Acturis; and Jack Henry & Associates. The company was founded in 1991 and is based in Shelton, Connecticut with additional locations in Naples, Florida; and Surrey, United Kingdom.

Full FLXI Calculator →

ABBVHealthcare

AbbVie is a pharmaceutical giant best known for Humira and newer blockbusters Skyrizi and Rinvoq. A Dividend Aristocrat with 52+ years of consecutive dividend increases. Strong free cash flow generation supports its above-average yield. The company's diversified pipeline reduces dependence on any single drug.

Full ABBV Calculator →
📬

Get this FLXI vs ABBV comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

FLXI vs SCHDFLXI vs JEPIFLXI vs OFLXI vs KOFLXI vs MAINFLXI vs JNJFLXI vs MRKFLXI vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.